Stock Report

Download full stock data and analysis for free Last Updated: 24-Sep-2026

Stock Rating

Is this stock worth it? Our ratings reveal the truth.

Wealth Insight New Issue

This month’s issue could change how you invest, read now.

Recently Viewed

Sai Life Sciences Peer Comparison

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

NSE: SAILIFE

₹1,609.60

up-down-arrow ₹9.10 (0.57%)

As on 23-Sep-2026IST

Market cap

info icon

₹34,201 Cr

Revenue (TTM)

info icon

₹2,250 Cr

P/E Ratio

info icon

94.5

P/B Ratio

info icon

13.4

Div. Yield

info icon

0 %

Edit peer-selector-edit
Sai Life Sciences Indegene Marksans Pharma Sanofi Consumer Healthcare India Dishman Carbogen
Market cap (₹ Cr)
 34,201 14,413 15,745 9,226 2,719
Revenue (₹ Cr)
 2,250 3,813 3,172 950 2,901
Net Profit (₹ Cr)
 361.74 400.90 521.27 266.00 16.16
Net Margin (%)
 15.77 10.30 15.92 27.44 0.55
RoE (%)
 15.47 13.87 18.10 72.69 0.29
Price to Earnings
 94.55 35.95 30.47 34.68 168.23
Price-To-Book
 13.40 4.49 4.95 26.52 0.41

Income Statement (₹ Cr)

Sai Life Sciences Indegene Marksans Pharma Sanofi Consumer Healthcare India Dishman Carbogen
Operating Revenue arrow
2,192.49 3,510.50 2,950.94 878.40 2,931.90
Total Income arrow
2,266.90 3,582.50 3,033.47 896.80 2,987.84
Total Expenditure arrow
1,584.97 2,891.50 2,350.16 569.40 2,366.27
EBITDA arrow
607.53 619.00 600.78 309.00 565.63
Depreciation arrow
166.86 126.40 98.63 11.70 338.69
EBIT arrow
440.67 492.60 502.15 297.30 226.94
Interest arrow
40.88 19.30 24.13 2.00 174.18
Other Income arrow
74.40 72.00 82.53 18.40 55.94
Exceptional Items arrow
-8.00 -20.30 -- 6.60 -3.80
Profit before Tax arrow
466.19 525.00 560.56 320.30 104.90
Provision for Tax arrow
117.28 123.90 140.49 80.20 7.45
Profit after Tax arrow
348.91 401.10 420.06 240.10 97.45

Liabilities (₹ Cr)

Sai Life Sciences Indegene Marksans Pharma Sanofi Consumer Healthcare India Dishman Carbogen
Shareholder's Funds arrow
2,483.69 3,138.70 3,023.16 384.00 6,676.90
Minority Interest arrow
-- -- 29.52 -- --
Non-Current Liabilities arrow
321.65 318.60 268.17 229.90 2,846.00
Current Liabilities arrow
904.59 1,086.20 527.09 128.40 2,317.05
Total Liabilities arrow
3,709.93 4,620.30 3,855.82 750.80 11,911.40

Assets (₹ Cr)

Sai Life Sciences Indegene Marksans Pharma Sanofi Consumer Healthcare India Dishman Carbogen
Non-Current Assets arrow
2,228.49 1,925.10 1,125.20 248.00 8,997.85
Current Assets arrow
1,481.44 2,618.40 2,722.74 494.30 2,842.10
Total Assets arrow
3,709.93 4,620.30 3,855.82 750.80 11,911.40
Total Debt* arrow
95.13 0.00 29.59 0.00 2,775.40
Net Current Assets arrow
576.85 1,532.20 2,195.65 365.90 525.05
Contingent Liabilities arrow
97.31 -- -- 1.50 428.74

Cashflow (₹ Cr)

Sai Life Sciences Indegene Marksans Pharma Sanofi Consumer Healthcare India Dishman Carbogen
Cash From Operating Activities arrow
509.13 650.80 458.13 174.80 491.45
Cash Flow from Investing Activities arrow
-395.41 -512.40 -248.27 7.60 -245.34
Cash from Financing Activities arrow
-123.68 -82.60 -70.93 -134.50 200.58
Net Cash Inflow / Outflow arrow
-9.96 55.80 138.93 47.90 446.69

Ratios

Profitability Ratios

 Sai Life Sciences Indegene Marksans Pharma Sanofi Consumer Healthcare India Dishman Carbogen
ROCE (%) arrow
20.97 18.92 21.10 98.11 3.21
ROE (%) arrow
15.16 14.14 15.31 73.20 1.56
ROA (%) arrow
10.09 10.31 11.85 37.26 0.89
EBIT Margin (%) arrow
31.10 19.68 23.16 37.27 21.20
Net Margin (%) arrow
15.39 11.20 13.85 26.77 3.26
Cash Profit Margin (%) arrow
23.50 15.03 17.07 27.35 14.88

Growth Ratios

 Sai Life Sciences Indegene Marksans Pharma Sanofi Consumer Healthcare India Dishman Carbogen
Revenue Growth (%) arrow
29.38 23.64 12.51 21.24 8.13
EBIT Growth (%) arrow
53.37 7.72 14.07 15.44 26.69
Net Profit Growth (%) arrow
105.08 -1.38 9.79 32.65 2,907.72
EPS Growth (%) arrow
101.82 -1.79 9.81 32.65 2,908.18
Book Value Growth (%) arrow
16.76 19.89 22.41 41.18 14.50

Valuation Ratios

 Sai Life Sciences Indegene Marksans Pharma Sanofi Consumer Healthcare India Dishman Carbogen
Price / Earnings arrow
58.91 26.06 17.04 43.36 20.92
Price / Book Value arrow
8.29 3.38 2.36 27.11 0.31
Dividend Yield (%) arrow
0.00 0.52 0.57 1.66 0.00
EV/EBITDA arrow
30.12 14.57 9.02 30.65 6.15
Market Cap (₹ Cr) arrow
20,554.39 10,450.76 7,121.50 10,410.62 2,038.26

Solvency Ratios

 Sai Life Sciences Indegene Marksans Pharma Sanofi Consumer Healthcare India Dishman Carbogen
Debt to Equity arrow
0.04 0.00 0.01 0.00 0.42
Short term debt to equity ratio arrow
0.03 -- 0.01 -- 0.13
Current Ratio arrow
1.64 2.41 5.17 3.85 1.23
Quick Ratio arrow
1.47 2.41 3.32 3.37 0.79
Interest Coverage arrow
12.40 28.20 24.24 161.15 1.60

Operating Efficiency Ratios

 Sai Life Sciences Indegene Marksans Pharma Sanofi Consumer Healthcare India Dishman Carbogen
Debtors to sales (%) arrow
17.04 27.97 21.84 3.37 22.95
Asset Turnover arrow
0.63 0.90 0.86 1.43 0.27
Receivable days arrow
60.56 90.10 71.16 8.58 83.29
Inventory Days arrow
22.43 0.00 109.20 20.38 119.47
Payable days arrow
194.31 -- 91.82 118.89 197.26
Cash Conversion Cycle arrow
-111.32 -- 88.55 -89.93 5.50
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...
loading...
loading...